-
Clinical testing service
- Tumor personalized liquid biopsy Lung cancer detection Gastric and colorectal cancer treatment target detection Female gynecological oncology Pan-cancerous solid tumor (multi-cancer) Chemotherapy guidance Hereditary tumor detection
- Tumor personalized clinical testing Lung cancer detection Gastric and colorectal cancer treatment target detection Female gynecological oncology Immunity therapy Pan-cancerous solid tumor (multi-cancer) Chemotherapy guidance Hereditary tumor detection
APP download
Tel: +86-571-89360709 E-mail: service@repugene.com
Address: 21-23, Health Valley, No. 1500, Wenyi West Road, Yuhang District, Hangzhou, Zhejiang, China
Copyright: Hangzhou Repugene Technology Co., Ltd. Powered by www.300.cn
浙ICP备16003170号
Address: 21-23, Health Valley, No. 1500, Wenyi West Road, Yuhang District, Hangzhou, Zhejiang, China
Copyright: Hangzhou Repugene Technology Co., Ltd. Powered by www.300.cn
浙ICP备16003170号
product service
Hangzhou Repugene Technology Co., Ltd. is a high-tech advanced biomedical research and development enterprise with the team of Dr. Haigui.
Lung cancer is a common malignant tumor, and its new morbidity and mortality rate has been very high. According to Chinese cancer statistics, the incidence of lung cancer in China has been high, which is the leading cause of cancer death in China. Lung cancer is mainly divided into two histological types of small cell lung cancer and non-small cell lung cancer, of which 80-85% are non-small cell lung cancer.
Lung cancer is a common malignant tumor, and its new morbidity and mortality rate has been very high. According to Chinese cancer statistics, the incidence of lung cancer in China has been high, which is the leading cause of cancer death in China. Lung cancer is mainly divided into two histological types of small cell lung cancer and non-small cell lung cancer, of which 80-85% are non-small cell lung cancer.
Page up
1
Page down